Clinical trial NCT03369392: PANDA-Regional Feasibility Study of a Smartphone Pain Management Application
Official title: The At-home Feasibility Evaluation of PANDA-Regional, a Smartphone Application Designed to Support Post-operative Pain Management in Patients Undergoing Peripheral Nerve Blocks
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Postoperative Pain
Anesthesia, Conduction
Lead sponsor: University of British Columbia
Sponsor class: OTHER
First posted: 2017-12-12
Enrollment: 29
Sex: ALL
Minimum age (years): 19
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: SEQUENTIAL
Primary purpose: OTHER

Brief summary: Despite the numerous benefits of peripheral nerve blocks (PNBs) over general anesthesia (GA) in a variety of surgical procedures, PNBs can be associated with increased post-operative pain if pain medications are not taken correctly (titrated). Unfortunately, this is a common occurrence as patients often have difficulty titrating medications in the absence of direct medical care. PANDA, a smartphone-based postoperative pain management tool, is designed to address this issue by helping patients manage their pain medications. The purpose of this study is to demonstrate the feasibility of this application in patients who are discharged after receiving PNBs. The goal is to identify areas of improvement for the application itself. It is hypothesize that PANDA will be successful in supporting patients' postoperative pain management.

Detailed description: As above

Eligibility criteria: Inclusion Criteria:

* Undergoing ambulatory surgical procedures that require peripheral nerve blocks for which there is an anticipated post-surgical pain model
* Planned post-discharge analgesic medications including non-steroidal anti-inflammatory drugs, acetaminophen and/or opioids for at least 2 days
* ASA I-III
* Written informed consent
* Have a smartphone device at their disposal

Exclusion Criteria:

* Inability or refusal to provide informed consent
* Presence of significant cognitive impairment, visual impairments, neurological injury, or psychomotor dysfunction that impairs ability to use the app
* Inability to follow study instructions and complete questionnaires in English

Primary outcomes:
measure: Feasibility of the PANDA application
timeFrame: 2-7 days post-operatively
Secondary outcomes:
measure: Identify usability issues
timeFrame: 2-7 days post-operatively
Other outcomes:
Locations:
city: Vancouver
country: Canada
facility: St. Paul's Hospital
state: British Columbia
Study officials:
affiliation: University of British Columbia
name: Ronald Ree, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: University of British Columbia
name: Cynthia Fan, MD
role: STUDY_CHAIR
affiliation: University of British Columbia
name: Mark Ansermino, MBBCH
role: STUDY_CHAIR
affiliation: University of British Columbia
name: Terri Sun, MD
role: STUDY_CHAIR
affiliation: University of British Columbia
name: Lily Yu Long Chiu, MD
role: STUDY_CHAIR
affiliation: University of British Columbia
name: Dustin Dunsmuir
role: STUDY_CHAIR
References:
citation: Dotto A, Dunsmuir D, Sun T, Chiu LYL, Ree R, Ansermino JM, Yarnold CH. The use of the Panda-Nerve Block pain app in single-shot peripheral nerve block patients: a feasibility study. Can J Anaesth. 2020 Sep;67(9):1140-1151. doi: 10.1007/s12630-020-01732-2. Epub 2020 Jun 4.